Pascal Marchand

15PUBLICATIONS
63CO-AUTHORS
Biomolecular modelling and designBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 10, 2026
Bicyclic Lactams From Chiral Imines: Synthesis, Structural Optimization, and Biological Evaluation of Promising Antileishmanial Agents.

|Jun 27, 2025
New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives.

José Rivaldo De Lima, Alexandre José Da Silva Góes, Elizabeth Fernanda De Oliveira Borba

|Jun 23, 2025
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy.

Lhana Tisseur, Cédric Logé, Sandrine Cojean

|Jan 25, 2025
2-Aminothiophene Derivatives-New Drug Candidates Against Leishmaniasis: Drug Design, Synthesis, Pharmacomodulation, and Antileishmanial Activity.

Rodrigo Santos Aquino de Araújo, Vitória Gaspar Bernardo, Robert da Silva Tibúrcio

|Dec 17, 2024
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.

Lhana Tisseur, Sandrine Cojean, Khadidiatou Gassama

|Apr 27, 2024
FRET Assays for the Identification of C. albicans HSP90-Sba1 and Human HSP90α-p23 Binding Inhibitors.

Philip Kohlmann, Sergey N Krylov, Pascal Marchand

Pageof 3

Frequent Collaborators

5 joint publications

Patrice Le Pape

4 joint publications

Isabelle Ourliac-Garnier

4 joint publications

Blandine Baratte

4 joint publications

Florence O McCarthy